NYSE:LCI - Lannett Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $13.60 -0.65 (-4.56 %) (As of 07/16/2018 03:06 AM ET)Previous Close$13.60Today's Range$13.60 - $14.4552-Week Range$12.70 - $30.35Volume486,447 shsAverage Volume729,939 shsMarket Capitalization$516.99 millionP/E Ratio4.76Dividend YieldN/ABeta2.57 Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. It also provides its products for various medical indications comprising glaucoma, cholesterol, muscle spasm, migraine, pain management, cardiovascular, antipsychosis, gastrointestinal, urinary, bronchospasms, respiratory, gallstone, congestive heart failure, thyroid deficiency, central nervous system, and gout. In addition, the company manufactures active pharmaceutical ingredients; and markets its products under the Diamox, Lipitor, Lioresal, Fioricet, Fiorinal, Lanoxin, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Metadate CD, Concerta, Procardia, Prilosec, Ditropan, Protonix, Imitrex, Brethine, Tussionex, and Actigall brands. Further, it sells pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with JSP, Summit Bioscience LLC, HEC Pharm Group, and Pharma Pass II LLC. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania. Receive LCI News and Ratings via Email Sign-up to receive the latest news and ratings for LCI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals SectorMedical SymbolNYSE:LCI CUSIP51601210 Webwww.lannett.com Phone215-333-9000 Debt Debt-to-Equity Ratio1.29 Current Ratio2.56 Quick Ratio1.91 Price-To-Earnings Trailing P/E Ratio4.76 Forward P/E Ratio4.36 P/E GrowthN/A Sales & Book Value Annual Sales$633.34 million Price / Sales0.82 Cash Flow$4.3871 per share Price / Cash3.10 Book Value$15.07 per share Price / Book0.90 Profitability EPS (Most Recent Fiscal Year)$2.86 Net Income$-580,000.00 Net Margins7.01% Return on Equity18.64% Return on Assets6.73% Miscellaneous Employees1,126 Outstanding Shares38,010,000Market Cap$516.99 Lannett (NYSE:LCI) Frequently Asked Questions What is Lannett's stock symbol? Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI." How were Lannett's earnings last quarter? Lannett Company, Inc. (NYSE:LCI) announced its quarterly earnings results on Monday, May, 7th. The company reported $0.80 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.76 by $0.04. The company earned $174.39 million during the quarter, compared to the consensus estimate of $176.51 million. Lannett had a net margin of 7.01% and a return on equity of 18.64%. The firm's quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.77 earnings per share. View Lannett's Earnings History. When is Lannett's next earnings date? Lannett is scheduled to release their next quarterly earnings announcement on Wednesday, August, 22nd 2018. View Earnings Estimates for Lannett. What price target have analysts set for LCI? 5 brokerages have issued 12-month target prices for Lannett's stock. Their forecasts range from $19.00 to $25.00. On average, they anticipate Lannett's share price to reach $21.50 in the next year. This suggests a possible upside of 58.1% from the stock's current price. View Analyst Ratings for Lannett. What is the consensus analysts' recommendation for Lannett? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lannett in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." Who are some of Lannett's key competitors? Some companies that are related to Lannett include Puma Biotechnology (PBYI), Myokardia (MYOK), Prestige Brands (PBH), Phibro Animal Health (PAHC), Insmed (INSM), Cambrex (CBM), Mallinckrodt (MNK), Aimmune Therapeutics (AIMT), PTC Therapeutics (PTCT), AnaptysBio (ANAB), Corcept Therapeutics (CORT), IMMURON Ltd/S (IMRN), Biohaven Pharmaceutical (BHVN), ARMO Biosciences (ARMO) and Innoviva (INVA). Who are Lannett's key executives? Lannett's management team includes the folowing people: Mr. Martin P. Galvan CPA, VP of Fin., CFO & Treasurer (Age 66)Mr. Robert Ehlinger, VP of Logistics & Chief Information Officer (Age 61)Mr. Kevin R. Smith, Sr. VP of Sales & Marketing (Age 58)Mr. John M. Abt, VP of Quality (Age 53)Mr. Arthur P. Bedrosian, Director (Age 72) Has Lannett been receiving favorable news coverage? News coverage about LCI stock has trended positive on Monday, Accern Sentiment reports. The research firm identifies negative and positive press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Lannett earned a media sentiment score of 0.36 on Accern's scale. They also assigned press coverage about the company an impact score of 45.05 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future. How do I buy shares of Lannett? Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Lannett's stock price today? One share of LCI stock can currently be purchased for approximately $13.60. How big of a company is Lannett? Lannett has a market capitalization of $516.99 million and generates $633.34 million in revenue each year. The company earns $-580,000.00 in net income (profit) each year or $2.86 on an earnings per share basis. Lannett employs 1,126 workers across the globe. How can I contact Lannett? Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at 215-333-9000. MarketBeat Community Rating for Lannett (NYSE LCI)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 361 (Vote Outperform)Underperform Votes: 277 (Vote Underperform)Total Votes: 638MarketBeat's community ratings are surveys of what our community members think about Lannett and other stocks. Vote "Outperform" if you believe LCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LCI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/16/2018 by MarketBeat.com StaffFeatured Article: What is a closed-end mutual fund (CEF)?